BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8910038)

  • 1. Epstein-Barr virus in tumours.
    Anagnostopoulos I; Hummel M
    Histopathology; 1996 Oct; 29(4):297-315. PubMed ID: 8910038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV-NK cells interactions and lymphoproliferative disorders.
    Kanegane H; Yachie A; Miyawaki T; Tosato G
    Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus as an agent of haematological disease.
    Tosato G; Taga K; Angiolillo AL; Sgadari C
    Baillieres Clin Haematol; 1995 Mar; 8(1):165-99. PubMed ID: 7663046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An animal model for Epstein-Barr virus (EBV)-associated lymphomagenesis in the human: malignant lymphoma induction of rabbits by EBV-related herpesvirus from cynomolgus.
    Hayashi K; Akagi T
    Pathol Int; 2000 Feb; 50(2):85-97. PubMed ID: 10792766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2015 Jan; 32(1):12-22. PubMed ID: 25804341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia.
    Ohtsubo H; Arima N; Tei C
    Leuk Lymphoma; 1999 May; 33(5-6):451-8. PubMed ID: 10342573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
    Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
    AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review.
    Anagnostopoulos I; Hummel M; Stein H
    Leuk Lymphoma; 1995 Sep; 19(1-2):1-12. PubMed ID: 8574154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Epstein-Barr virus-infected cells in benign lymphadenopathy of patients seropositive for human immunodeficiency virus.
    Brousset P; Schlaifer D; Roda D; Massip P; Marchou B; Delsol G
    Hum Pathol; 1996 Mar; 27(3):263-8. PubMed ID: 8600041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epstein-Barr virus].
    Nicolas JC; Maréchal V; Dehée A
    Bull Acad Natl Med; 1997; 181(6):981-96; discussion 996-7. PubMed ID: 9453844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus strain characterization.
    Munch M
    APMIS; 1998 Apr; 106(4):425-33. PubMed ID: 9637263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
    Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
    Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression.
    Sugawara Y; Mizugaki Y; Uchida T; Torii T; Imai S; Makuuchi M; Takada K
    Virology; 1999 Apr; 256(2):196-202. PubMed ID: 10191184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection and human malignancies.
    Niedobitek G; Meru N; Delecluse HJ
    Int J Exp Pathol; 2001 Jun; 82(3):149-70. PubMed ID: 11488990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome.
    Katz BZ; Berkman AB; Shapiro ED
    J Pediatr; 1992 Feb; 120(2 Pt 1):228-32. PubMed ID: 1310507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus: pathologic implications].
    Kafé H; Wechsler J; Gaulard P; Gosselin B
    Ann Pathol; 1998 Feb; 18(1):16-28. PubMed ID: 9551155
    [No Abstract]   [Full Text] [Related]  

  • 19. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.